TY  - GEN
AU  - Sandul,Amy L
AU  - Nwana,Nwabunie
AU  - Holcombe,J Mike
AU  - Lobato,Mark N
AU  - Marks,Suzanne
AU  - Webb,Risa
AU  - Wang,Shu-Hua
AU  - Stewart,Brock
AU  - Griffin,Phil
AU  - Hunt,Garrett
AU  - Shah,Neha
AU  - Marco,Asween
AU  - Patil,Naveen
AU  - Mukasa,Leonard
AU  - Moro,Ruth N
AU  - Jereb,John
AU  - Mase,Sundari
AU  - Chorba,Terence
AU  - Bamrah-Morris,Sapna
AU  - Ho,Christine S
TI  - High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection
SN  - 1537-6591
PY  - 2019///0702
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibiotics, Antitubercular
KW  - adverse effects
KW  - Antitubercular Agents
KW  - Child
KW  - Child, Preschool
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - etiology
KW  - Female
KW  - Ill-Housed Persons
KW  - Humans
KW  - Isoniazid
KW  - Latent Tuberculosis
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Mycobacterium tuberculosis
KW  - drug effects
KW  - Rifampin
KW  - Students
KW  - United States
KW  - Young Adult
N1  - Publication Type: Journal Article; Observational Study; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1093/cid/cix505
ER  -